New Zealanders with advanced melanoma, Hepatitis C, forms of lung disease, brain tumours, kidney disease and menopause are set to benefit from new publicly funded drugs.
New Zealanders with advanced melanoma, Hepatitis C, forms of lung disease, brain tumours, kidney disease and menopause are set to benefit from new publicly funded drugs.